Literature DB >> 12404642

Protease inhibitors formed in situ from copper and tridentate chelates: a generalized approach towards metal-based pharmaceuticals.

Christopher J Brinkerhoff1, Paul Podsiadlo, Tomoko Komiyama, Robert S Fuller, Ofer Blum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12404642     DOI： 10.1002/1439-7633(20021104)3:11<1141::AID-CBIC1141>3.0.CO;2-7

Source DB:  PubMed          Journal:  Chembiochem        ISSN： 1439-4227            Impact factor:   3.164


× No keyword cloud information.
  4 in total

1.  Inhibition of prohormone convertases PC1/3 and PC2 by 2,5-dideoxystreptamine derivatives.

Authors:  Mirella Vivoli; Thomas R Caulfield; Karina Martínez-Mayorga; Alan T Johnson; Guan-Sheng Jiao; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2011-12-14       Impact factor: 4.436

Review 2.  Inhibitors of proprotein convertases.

Authors:  Ajoy Basak
Journal:  J Mol Med (Berl)       Date:  2005-10-08       Impact factor: 4.599

Review 3.  Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibition.

Authors:  Martin Fugère; Robert Day
Journal:  Trends Pharmacol Sci       Date:  2005-06       Impact factor: 14.819

4.  Design of peptide inhibitors for furin based on the C-terminal fragment of histone H1.2.

Authors:  Suming Wang; Jinbo Han; Yanfang Wang; Wuyuan Lu; Chengwu Chi
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-10       Impact factor: 3.848
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.